True and False Concerns About Neuroenhancement: A Response to ‘Neuroenhancers, Addiction and Research Ethics’, by D M Shaw.
True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw.
J Med Ethics. 2013 Mar 6;
Heinz A, Kipke R, Müller S, Wiesing U
In his critical comment on our paper… Continue reading
The Μ Opioid Receptor and Ligands Acting at the Μ Opioid Receptor, as Therapeutics and Potential Therapeutics.
The µ Opioid Receptor and Ligands Acting at the µ Opioid Receptor, as Therapeutics and Potential Therapeutics.
Curr Pharm Des. 2013 Feb 20;
Spetea M, Asim MF, Wolber G, Schmidhammer H
Although the µ opioid receptor (MOR) was pharmacologically… Continue reading
Natural and Drug Rewards Act on Common Neural Plasticity Mechanisms With ?FosB as a Key Mediator.
Natural and Drug Rewards Act on Common Neural Plasticity Mechanisms with ?FosB as a Key Mediator.
J Neurosci. 2013 Feb 20; 33(8): 3434-3442
Pitchers KK, Vialou V, Nestler EJ, Laviolette SR, Lehman MN, Coolen LM
Drugs of abuse induce… Continue reading
Addiction Rehab: Modulating Cocaine Vaccine Potency Through Hapten Fluorination.
Modulating Cocaine Vaccine Potency Through Hapten Fluorination.
Filed under: Addiction Rehab
J Am Chem Soc. 2013 Feb 11;
Cai X, Tsuchikama K, Janda KD
Cocaine addiction is a long-lasting relapsing illness characterized by cycles of abuse, abstinence and reinstatement,… Continue reading
Integrating Substance Abuse Care With Community Diabetes Care: Implications for Research and Clinical Practice.
Integrating substance abuse care with community diabetes care: implications for research and clinical practice.
Filed under: Addiction Rehab
Subst Abuse Rehabil. 2013 Jan 1; 4: 3-10
Ghitza UE, Wu LT, Tai B
Cigarette smoking and alcohol use are prevalent… Continue reading